It's an inevitable step in the evolution of healthcare -- and one that could help Illumina grow into its premium valuation.
News & Analysis: Qiagen N.V.
QGEN earnings call for the period ending September 30, 2019.
Investors are wondering whether to welcome or fear Qiagen’s recent announcement about its CEO’s departure, slowing sales, and business restructuring.
Even kind words from Wall Street pros aren't always enough to lift a stock.
A trio of news items has the healthcare company in transition.
The test maker trudges along.
QGEN earnings call for the period ending June 30, 2019.
The QIAstat should accelerate growth for the diagnostic testing company.
QGEN earnings call for the period ending March 31, 2019.
With new products, growth at the diagnostic test company is set to accelerate this year.